https://www.selleckchem.com/pr....oducts/salubrinal.ht
The exercise group demonstrated significant improvement in VO at 10weeks compared with controls (33.8 ± 8.1vs 29.6 ± 7.6mL.kg .min , P=0.0002), but by six months, the difference was no longer significant (32.9 ± 7.0vs 30.9 ± 11.0mL.kg .min , P=0.21). There were no significant differences in fatigue or total QOL scores between groups. Cancer treatment is associated with reduced VO in AYA. Improvement in VO was accelerated by a 10-week exercise program; however, no significant benefit was observed in QOL or fatigue. The plateau in VO a